Global Blood Therapeutics, Inc.
(NASDAQ : GBT)

( )
GBT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.04%202.891.3%$439.73m
BIIBBiogen Inc.
1.14%225.761.3%$382.28m
GILDGilead Sciences, Inc.
0.81%64.510.9%$362.26m
CELGCelgene Corporation
-0.18%100.391.3%$352.37m
ILMNIllumina, Inc.
2.56%310.313.5%$266.69m
REGNRegeneron Pharmaceuticals, Inc.
1.55%305.442.6%$219.74m
EXASExact Sciences Corporation
2.54%94.8524.1%$199.38m
ALXNAlexion Pharmaceuticals, Inc.
2.11%101.342.0%$181.06m
VRTXVertex Pharmaceuticals Incorporated
0.68%173.591.9%$178.83m
AAgilent Technologies, Inc.
-0.16%75.181.6%$153.77m
SRPTSarepta Therapeutics, Inc.
2.66%85.7014.6%$141.72m
ALDRAlder Biopharmaceuticals, Inc.
0.27%18.9210.2%$132.33m
BMRNBioMarin Pharmaceutical Inc.
-0.18%67.244.3%$95.95m
ACADACADIA Pharmaceuticals Inc.
-2.57%39.4813.4%$89.57m
SGENSeattle Genetics, Inc.
-0.22%82.426.2%$84.75m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.